Balyasny Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,300,604
| Closed | -$1.65M | – | 2103 |
|
|
2024
Q4 | $1.65M | Buy |
1,300,604
+1,126,569
| +647% | +$1.43M | ﹤0.01% | 1143 |
|
|
2024
Q3 | $593K | Buy |
174,035
+136,068
| +358% | +$464K | ﹤0.01% | 1497 |
|
|
2024
Q2 | $177K | Sell |
37,967
-254,743
| -87% | -$1.19M | ﹤0.01% | 1718 |
|
|
2024
Q1 | $2.17M | Buy |
292,710
+233,387
| +393% | +$1.73M | ﹤0.01% | 1070 |
|
|
2023
Q4 | $601K | Buy |
+59,323
| New | +$601K | ﹤0.01% | 1355 |
|
|
2023
Q1 | – | Sell |
-345,940
| Closed | -$3.07M | – | 2310 |
|
|
2022
Q4 | $3.07M | Buy |
345,940
+260,737
| +306% | +$2.31M | 0.01% | 901 |
|
|
2022
Q3 | $1.04M | Sell |
85,203
-229,044
| -73% | -$2.8M | ﹤0.01% | 1360 |
|
|
2022
Q2 | $3.72M | Buy |
+314,247
| New | +$3.72M | 0.01% | 868 |
|
|
2021
Q3 | – | Sell |
-29,902
| Closed | -$1.69M | – | 1768 |
|
|
2021
Q2 | $1.69M | Buy |
+29,902
| New | +$1.69M | 0.01% | 953 |
|
|
2019
Q3 | – | Sell |
-118,993
| Closed | -$2.94M | – | 1129 |
|
|
2019
Q2 | $2.94M | Buy |
118,993
+90,126
| +312% | +$2.23M | 0.02% | 651 |
|
|
2019
Q1 | $706K | Sell |
28,867
-10,197
| -26% | -$249K | ﹤0.01% | 1006 |
|
|
2018
Q4 | $889K | Buy |
+39,064
| New | +$889K | 0.01% | 836 |
|
|
2018
Q3 | – | Sell |
-9,880
| Closed | -$354K | – | 1510 |
|
|
2018
Q2 | $354K | Sell |
9,880
-16,761
| -63% | -$601K | ﹤0.01% | 1282 |
|
|
2018
Q1 | $883K | Buy |
+26,641
| New | +$883K | ﹤0.01% | 1072 |
|
|
2017
Q1 | – | Sell |
-94,800
| Closed | -$1.54M | – | 1425 |
|
|
2016
Q4 | $1.54M | Buy |
94,800
+34,800
| +58% | +$565K | 0.01% | 747 |
|
|
2016
Q3 | $809K | Buy |
+60,000
| New | +$809K | ﹤0.01% | 686 |
|